                         SEQUENCE LISTING

<110>  INSERM
 
<120>  Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) 
       and uses thereof

<130>  BIO09360 GIBOT

<160>  9     

<170>  PatentIn version 3.3

<210>  1
<211>  311
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Leu Thr Leu Leu Leu Leu Leu Leu Leu Gly Leu Glu Gly Gln 
1               5                   10                  15      


Gly Ile Val Gly Ser Leu Pro Glu Val Leu Gln Ala Pro Val Gly Ser 
            20                  25                  30          


Ser Ile Leu Val Gln Cys His Tyr Arg Leu Gln Asp Val Lys Ala Gln 
        35                  40                  45              


Lys Val Trp Cys Arg Phe Leu Pro Glu Gly Cys Gln Pro Leu Val Ser 
    50                  55                  60                  


Ser Ala Val Asp Arg Arg Ala Pro Ala Gly Arg Arg Thr Phe Leu Thr 
65                  70                  75                  80  


Asp Leu Gly Gly Gly Leu Leu Gln Val Glu Met Val Thr Leu Gln Glu 
                85                  90                  95      


Glu Asp Ala Gly Glu Tyr Gly Cys Met Val Asp Gly Ala Arg Gly Pro 
            100                 105                 110         


Gln Ile Leu His Arg Val Ser Leu Asn Ile Leu Pro Pro Glu Glu Glu 
        115                 120                 125             


Glu Glu Thr His Lys Ile Gly Ser Leu Ala Glu Asn Ala Phe Ser Asp 
    130                 135                 140                 


Pro Ala Gly Ser Ala Asn Pro Leu Glu Pro Ser Gln Asp Glu Lys Ser 
145                 150                 155                 160 


Ile Pro Leu Ile Trp Gly Ala Val Leu Leu Val Gly Leu Leu Val Ala 
                165                 170                 175     


Ala Val Val Leu Phe Ala Val Met Ala Lys Arg Lys Gln Gly Asn Arg 
            180                 185                 190         


Leu Gly Val Cys Gly Arg Phe Leu Ser Ser Arg Val Ser Gly Met Asn 
        195                 200                 205             


Pro Ser Ser Val Val His His Val Ser Asp Ser Gly Pro Ala Ala Glu 
    210                 215                 220                 


Leu Pro Leu Asp Val Pro His Ile Arg Leu Asp Ser Pro Pro Ser Phe 
225                 230                 235                 240 


Asp Asn Thr Thr Tyr Thr Ser Leu Pro Leu Asp Ser Pro Ser Gly Lys 
                245                 250                 255     


Pro Ser Leu Pro Ala Pro Ser Ser Leu Pro Pro Leu Pro Pro Lys Val 
            260                 265                 270         


Leu Val Cys Ser Lys Pro Val Thr Tyr Ala Thr Val Ile Phe Pro Gly 
        275                 280                 285             


Gly Asn Lys Gly Gly Gly Thr Ser Cys Gly Pro Ala Gln Asn Pro Pro 
    290                 295                 300                 


Asn Asn Gln Thr Pro Ser Ser 
305                 310     


<210>  2
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  2

Ser Ala Val Asp Arg Arg Ala Pro Ala Gly Arg Arg 
1               5                   10          


<210>  3
<211>  14
<212>  PRT
<213>  Homo sapiens

<400>  3

Cys Met Val Asp Gly Ala Arg Gly Pro Gln Ile Leu His Arg 
1               5                   10                  


<210>  4
<211>  17
<212>  PRT
<213>  Homo sapiens

<400>  4

Leu Gln Glu Glu Asp Ala Gly Glu Tyr Gly Cys Met Val Asp Gly Ala 
1               5                   10                  15      


Arg 
    


<210>  5
<211>  17
<212>  PRT
<213>  Homo sapiens

<400>  5

Gly Ala Glu Arg Glu Val Cys Met Asp Glu Tyr Gly Ala Leu Gln Asp 
1               5                   10                  15      


Gly 
    


<210>  6
<211>  6
<212>  PRT
<213>  Homo sapiens

<400>  6

Leu Gln Glu Glu Asp Ala 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Homo sapiens

<400>  7

Glu Asp Ala Gly Glu Tyr 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Homo sapiens

<400>  8

Gly Glu Tyr Gly Cys Met 
1               5       


<210>  9
<211>  12
<212>  PRT
<213>  Homo sapiens

<400>  9

Leu Gln Glu Glu Asp Ala Gly Glu Tyr Gly Cys Met 
1               5                   10          


